These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 36354205)
21. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982 [TBL] [Abstract][Full Text] [Related]
22. Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a. Lin C; Zheng M; Yang Y; Chen Y; Zhang X; Zhu L; Zhang H Bioengineered; 2022 Apr; 13(4):9829-9838. PubMed ID: 35412951 [TBL] [Abstract][Full Text] [Related]
23. lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF. Zou MJ; Cheng XR; Liu RF J Obstet Gynaecol Res; 2022 Jul; 48(7):1836-1847. PubMed ID: 35388952 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis. Li G; Yan X J Orthop Surg Res; 2023 Nov; 18(1):890. PubMed ID: 37993867 [TBL] [Abstract][Full Text] [Related]
25. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p. Xiong S; Song H Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776 [TBL] [Abstract][Full Text] [Related]
26. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
27. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis. Dong B; Zhang F; Zhang W; Gao Y Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855 [TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA Xie F; Xie G; Sun Q Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747 [No Abstract] [Full Text] [Related]
29. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells. Zhou X; Zhao X; Wu Z; Ma Y; Li H Bioengineered; 2022 Apr; 13(4):10454-10466. PubMed ID: 35465835 [TBL] [Abstract][Full Text] [Related]
30. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p. Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190 [TBL] [Abstract][Full Text] [Related]
31. HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis. Guo J; Dou D; Zhang T; Wang B Cell Transplant; 2020; 29():963689720948447. PubMed ID: 32757663 [TBL] [Abstract][Full Text] [Related]
32. DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p. Wu N; Song H; Ren Y; Tao S; Li S Cell Biochem Funct; 2020 Oct; 38(7):870-879. PubMed ID: 32283566 [TBL] [Abstract][Full Text] [Related]
33. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp. Shen JG; Xu SN; Yin LG Gen Physiol Biophys; 2020 Sep; 39(5):481-489. PubMed ID: 33084601 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
35. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway. Cai Y; Dong ZY; Wang JY Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323 [TBL] [Abstract][Full Text] [Related]
36. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis. Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486 [TBL] [Abstract][Full Text] [Related]
37. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma. Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761 [TBL] [Abstract][Full Text] [Related]
38. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway. Zhang P; Zhao F; Jia K; Liu X Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607 [TBL] [Abstract][Full Text] [Related]
39. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Liu Y; Guo R; Qiao Y; Han L; Liu M Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326 [TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer. Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]